Arcutis Biotherapeutics, Inc.
ARQT
$31.08
$1.123.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.20% | -47.35% | -50.95% | -16.15% | 45.55% |
| Total Receivables | 91.48% | 145.76% | 129.89% | 183.12% | 209.62% |
| Inventory | 59.96% | 17.61% | 25.42% | 10.60% | 0.73% |
| Prepaid Expenses | 16.66% | -25.93% | 21.51% | 21.70% | -53.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.19% | 226.01% | 1,122.20% | -16.23% | 932.65% |
| Total Current Assets | -17.58% | -23.43% | -30.85% | 1.63% | 50.50% |
|
|
|||||
| Total Current Assets | -17.58% | -23.43% | -30.85% | 1.63% | 50.50% |
| Net Property, Plant & Equipment | 78.13% | -11.05% | -8.12% | -23.23% | -22.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 57.02% | 162.86% | 164.00% | 47.24% | 47.80% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.17% | 0.00% | 0.00% | 0.00% |
| Total Assets | -15.18% | -20.76% | -28.09% | 2.20% | 49.29% |
|
|
|||||
| Total Accounts Payable | -70.01% | 89.88% | 89.14% | 18.58% | 46.63% |
| Total Accrued Expenses | 76.12% | 106.08% | 95.80% | 94.38% | 88.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -99.00% | 28.70% | 11.38% | 11.56% | 13,929.51% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -42.14% | 102.40% | 92.63% | 73.59% | 311.63% |
|
|
|||||
| Total Current Liabilities | -42.14% | 102.40% | 92.63% | 73.59% | 311.63% |
| Long-Term Debt | 2.29% | -47.48% | -46.93% | -46.88% | -47.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.33% | -29.01% | -26.44% | -24.25% | -22.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -14.29% | 85.57% | 17.65% | -32.86% | -- |
| Total Liabilities | -24.16% | -17.37% | -20.56% | -24.28% | 14.00% |
|
|
|||||
| Common Stock & APIC | 3.66% | 3.63% | 3.82% | 19.52% | 31.66% |
| Retained Earnings | -3.99% | -8.72% | -12.75% | -14.26% | -21.36% |
| Treasury Stock & Other | -111.63% | 88.10% | -5.26% | -275.00% | 389.67% |
| Total Common Equity | 0.91% | -25.45% | -36.58% | 77.68% | 235.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.91% | -25.45% | -36.58% | 77.68% | 235.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.91% | -25.45% | -36.58% | 77.68% | 235.30% |
|
|
|||||